SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-005892
Filing Date
2020-01-13
Accepted
2020-01-13 07:15:32
Documents
3
Period of Report
2020-01-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d851491d8k.htm 8-K 20674
2 EX-99.1 d851491dex991.htm EX-99.1 14007
3 GRAPHIC g851491logo.jpg GRAPHIC 4822
  Complete submission text file 0001193125-20-005892.txt   42624
Mailing Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080
Business Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080 650-870-1000
Calithera Biosciences, Inc. (Filer) CIK: 0001496671 (see all company filings)

IRS No.: 272366329 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36644 | Film No.: 20522751
SIC: 2834 Pharmaceutical Preparations